Evidence map›Paper›PMID 32434960›Full record

ArticleAging2020

Human amnion-derived mesenchymal stem cells promote osteogenic differentiation of human bone marrow mesenchymal stem cells via H19/miR-675/APC axis.

Xiaojie Ma, Yifeng Bian, Hua Yuan, Ning Chen, Yongchu Pan, Weina Zhou, Shiyu Gao, Xin Du, Shushu Hao, Zixin Yan and 5 more

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Long noncoding RNA (lncRNA)Genes & diseases · 2023
    Review
  8. Review
  9. Article
  10. MicroRNA-loaded biomaterials for osteogenesis.Frontiers in bioengineering and biotechnology · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Xiaojie MaJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Yifeng BianJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Hua YuanJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Ning ChenJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Yongchu PanJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Weina ZhouJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Shiyu GaoJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Xin DuState Key Laboratory of Bioelectronics, Southeast University, Nanjing, China.
Shushu HaoJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Zixin YanJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Xuan LiJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Keyue LiuJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Fan XuJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Yuli WangJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Yifei DuJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNSoutheast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone volume inadequacy is an emerging clinical problem impairing the feasibility and longevity of dental implants. Human bone marrow mesenchymal stem cells (HBMSCs) have been widely used in bone remodeling and regeneration. This study examined the effect of long noncoding RNAs (lncRNAs)-H19 on the human amnion-derived mesenchymal stem cells (HAMSCs)-droved osteogenesis in HBMSCs. HAMSCs and HBMSCs were isolated from abandoned amniotic membrane samples and bone marrow. The coculture system was conducted using transwells, and H19 level was measured by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR). The mechanism was further verified. We here discovered that osteogenesis of HBMSCs was induced by HAMSCs, while H19 level in HAMSCs was increased during coculturing. H19 had no significant effect on the proliferative behaviors of HBMSCs, while its overexpression of H19 in HAMSCs led to the upregulated osteogenesis of HBMSCs

Indexed as

Adenomatous Polyposis Coli ProteinAmnionAnimalsBone Marrow CellsCell DifferentiationCells, CulturedCoculture TechniquesDental ImplantationDisease Models, AnimalFemaleHumansMandibleMandibular InjuriesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMicroRNAsAdenomatous Polyposis Coli ProteinAPC protein, humanH19 long non-coding RNAMicroRNAsMIRN675 microRNA, humanRNA, Long Noncodingadenomatous polyposis colihuman amnion-derived mesenchymal stem cellslong noncoding RNA H19miR-675osteogenic differentiation

Identifiers

PMID32434960
PMCPMC7346082
OpenAlexW3027834264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.